Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Jun;326(2):181-5.
doi: 10.1007/BF00517317.

Inhibition of cigarette smoke-induced oedema in the nasal mucosa by capsaicin pretreatment and a substance P antagonist

Inhibition of cigarette smoke-induced oedema in the nasal mucosa by capsaicin pretreatment and a substance P antagonist

J M Lundberg et al. Naunyn Schmiedebergs Arch Pharmacol. 1984 Jun.

Abstract

The effect of cigarette smoke on vascular permeability in the rat nasal mucosa was studied using the Evans blue extravasation method. Exposure to smoke from cigarettes induced a significant extravasation of Evans blue in the nasal mucosa of normal rats, suggesting an increased vascular permeability to plasma proteins. The oedema response was correlated to tar, nicotine and vapour phase components in the smoke. The smoke-induced permeability effect was abolished in rats pretreated neonatally with capsaicin. Also, systemic or local pretreatment with [D-Arg, D-Pro, D-Trp, Leu]Substance P, a substance P antagonist, inhibited the permeability response to cigarette smoke. Insertion of a glass-fibre filter, which removes the particulate phase of the smoke (including nicotine), did not significantly reduce the permeability response. The present findings suggest that the smoke-induced oedema in the rat nasal mucosa is not caused by nicotine but by vapour-phase irritants, which activate capsaicin-sensitive C-fibre afferents. These neurons then release agents such as substance P or a related tachykinin which increase permeability to plasma proteins.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Naunyn Schmiedebergs Arch Pharmacol. 1984 Jun;326(3):254-61 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1983 Nov;324(3):212-8 - PubMed
    1. Eur J Pharmacol. 1980 Mar 7;62(1):27-34 - PubMed
    1. J Neurocytol. 1981 Dec;10(6):963-80 - PubMed
    1. Acta Physiol Acad Sci Hung. 1961;19:113-32 - PubMed

Publication types

LinkOut - more resources